These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 28616573)

  • 1. YAP and the Hippo pathway in pediatric cancer.
    Ahmed AA; Mohamed AD; Gener M; Li W; Taboada E
    Mol Cell Oncol; 2017; 4(3):e1295127. PubMed ID: 28616573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Regulatory Role of KIBRA and PTPN14 in Hippo Signaling and Beyond.
    Wilson KE; Yang N; Mussell AL; Zhang J
    Genes (Basel); 2016 May; 7(6):. PubMed ID: 27240404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Review: Molecular Aberrations within Hippo Signaling in Bone and Soft-Tissue Sarcomas.
    Deel MD; Li JJ; Crose LE; Linardic CM
    Front Oncol; 2015; 5():190. PubMed ID: 26389076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of TAZ and YAP crosstalk with TGFβ signalling in canine osteosarcoma suggests involvement of hippo signalling in disease progression.
    Luu AK; Schott CR; Jones R; Poon AC; Golding B; Hamed R; Deheshi B; Mutsaers A; Wood GA; Viloria-Petit AM
    BMC Vet Res; 2018 Nov; 14(1):365. PubMed ID: 30477496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy.
    Juan WC; Hong W
    Genes (Basel); 2016 Aug; 7(9):. PubMed ID: 27589805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Hippo Pathway-YAP/TAZ Signaling in Angiogenesis.
    Boopathy GTK; Hong W
    Front Cell Dev Biol; 2019; 7():49. PubMed ID: 31024911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the Hippo pathway in heart repair.
    Meng F; Xie B; Martin JF
    Cardiovasc Res; 2022 Aug; 118(11):2402-2414. PubMed ID: 34528077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WW Domain-Containing Proteins YAP and TAZ in the Hippo Pathway as Key Regulators in Stemness Maintenance, Tissue Homeostasis, and Tumorigenesis.
    Chen YA; Lu CY; Cheng TY; Pan SH; Chen HF; Chang NS
    Front Oncol; 2019; 9():60. PubMed ID: 30805310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Hippo-YAP pathway: new connections between regulation of organ size and cancer.
    Zhao B; Lei QY; Guan KL
    Curr Opin Cell Biol; 2008 Dec; 20(6):638-46. PubMed ID: 18955139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Hippo signaling pathway provides novel anti-cancer drug targets.
    Bae JS; Kim SM; Lee H
    Oncotarget; 2017 Feb; 8(9):16084-16098. PubMed ID: 28035075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cell regulation by the Hippo pathway.
    Hiemer SE; Varelas X
    Biochim Biophys Acta; 2013 Feb; 1830(2):2323-34. PubMed ID: 22824335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease.
    Varelas X
    Development; 2014 Apr; 141(8):1614-26. PubMed ID: 24715453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms.
    Dobrokhotov O; Samsonov M; Sokabe M; Hirata H
    Clin Transl Med; 2018 Aug; 7(1):23. PubMed ID: 30101371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Hippo Pathway: Biology and Pathophysiology.
    Ma S; Meng Z; Chen R; Guan KL
    Annu Rev Biochem; 2019 Jun; 88():577-604. PubMed ID: 30566373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YAP/TAZ: a promising target for squamous cell carcinoma treatment.
    Dong X; Meng L; Liu P; Ji R; Su X; Xin Y; Jiang X
    Cancer Manag Res; 2019; 11():6245-6252. PubMed ID: 31360073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hippo Signaling in Cancer: Lessons From
    Snigdha K; Gangwani KS; Lapalikar GV; Singh A; Kango-Singh M
    Front Cell Dev Biol; 2019; 7():85. PubMed ID: 31231648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newcomers to the WW Domain-Mediated Network of the Hippo Tumor Suppressor Pathway.
    Sudol M
    Genes Cancer; 2010 Nov; 1(11):1115-8. PubMed ID: 21779434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Celastrol as a Novel YAP-TEAD Inhibitor for Cancer Therapy by High Throughput Screening with Ultrasensitive
    Nouri K; Azad T; Ling M; Janse van Rensburg HJ; Pipchuk A; Shen H; Hao Y; Zhang J; Yang X
    Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31635084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the Hippo Pathway and Cancer through the TEAD Family of Transcription Factors.
    Holden JK; Cunningham CN
    Cancers (Basel); 2018 Mar; 10(3):. PubMed ID: 29558384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circular RNAs modulate Hippo-YAP signaling: functional mechanisms in cancer.
    Qadir J; Li F; Yang BB
    Theranostics; 2022; 12(9):4269-4287. PubMed ID: 35673576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.